Top Stocks to Watch: Grasim, Sun Pharma, Power Grid Corp., Nykaa, and Garden Reach Surge in Market Trends

<ul>
  <li>Grasim Industries has reported a significant 15.5% year-on-year (YoY) increase in its Q4FY24 consolidated net profit, reaching ₹2,721.81 crore.</li>
  <li>Sun Pharmaceutical Industries has surpassed estimates with a Q4 consolidated net profit of ₹2,655 crore, driven by robust performance in the U.S. and domestic markets.</li>
  <li>Power Grid Corporation of India announced a nearly 4% fall in its Q4 consolidated net profit, attributed to a marginal decline in income.</li>
</ul>
<p><strong>Stay updated with the latest financial results and market insights from top companies like Grasim Industries, Sun Pharma, and Power Grid Corporation.</strong></p>

<h2><strong>Grasim Industries Reports Strong Q4FY24 Results</strong></h2>
<p>Grasim Industries has reported a 15.5% YoY rise in its Q4FY24 consolidated net profit, reaching ₹2,721.81 crore, up from ₹2,355.67 crore in Q4FY23. The company's revenue from operations also saw a 13% increase, totaling ₹37,727.1 crore. The EBITDA for Q4FY24 stood at ₹6,196 crore, marking a 27% growth YoY. For the full FY24, the consolidated net profit was ₹9,925.65 crore. The company achieved an all-time high consolidated revenue of ₹1,30,978 crore for FY24, up by 11% year-on-year, driven by strong performance from its diversified businesses portfolio, particularly the building materials and financial services businesses. The EBITDA for the year reached a record level of ₹20,837 crore.</p>

<h3><strong>Sun Pharmaceutical Industries Exceeds Expectations</strong></h3>
<p>Sun Pharmaceutical Industries reported a Q4 consolidated net profit of ₹2,655 crore ($318.9 million), surpassing estimates. This impressive performance was driven by strong sales in the U.S. and domestic markets. The company's total revenue rose 9.6% to ₹11,983 crore. U.S. sales increased by nearly 11.9% to ₹3,954 crore, while India sales rose by more than 10.2% to ₹3,710 crore. The board has proposed a dividend of ₹5 per share for fiscal year 2024.</p>

<h3><strong>Power Grid Corporation of India Faces Profit Decline</strong></h3>
<p>Power Grid Corporation of India announced a nearly 4% fall in its Q4 consolidated net profit, which stood at ₹4,166.33 crore. This decline was mainly due to a marginal decrease in income. However, for FY24, PowerGrid's consolidated net profit rose to ₹15,573.16 crore. The board recommended a final dividend of ₹2.75 per equity share for FY24 and approved fund raising of ₹5,000 crore.</p>

<h3><strong>Conclusion</strong></h3>
<p>The financial results of Grasim Industries, Sun Pharmaceutical Industries, and Power Grid Corporation of India highlight the varying performance trends in the market. While Grasim and Sun Pharma have shown significant growth, Power Grid faced a slight decline in profit. Investors should keep a close watch on these companies as they navigate the financial landscape, with Grasim and Sun Pharma showing promising growth trajectories and Power Grid focusing on strategic fund raising to bolster its future prospects.</p>